- Email: [email protected]
Determination of collagen genotype (S Ralston et al, RU)
l
les derniers brevets dkposes realisee en collaboration
Pro vti > Cultivation of petunia Ohtani et a/, JP)
(T
National Research Institute of Agricultural Engineering, Ministry of Agriculture, Forestry and Fisheries N"799564,
EP
To make it possible to control the external view of flowers of petunias not by breeding but by only controlling cultivation environment... Especially, to broaden the outer margin in the corolla of the petunia, it is preferable to use yellow light as the cultivation light, and to narrow it, blue light as the light quality.
The Ohio State Research Foundation NOW0 97/32016, PCT . . . comprises combining the plant and a vector which contains the foreign nucleic acid to be introduced into the plant sample. Preferably the plant sample is sonicated in the presence of the vector. The vector is preferably non-tumor inducing bacteria more preferably Agrobacteviurn... After sonicating the plant sample is cultured under conditions that induce morphogenesis to produce plant tissue that will mature into a transformed plant. > Plastid transformation in Arabidopsis thaliana Maliga et al, IN)
Rutgers University, and the inventors NOW0 97132977,
> Cultivation of flowering plants (T Ohtani et al, JP)
National Research Institute of Agricultural Engineering, Ministry of Agriculture, Forestry and Fisheries N” 799565, EP. To make it possible to control the forms of flowering plants by controlling light quality of cultivation light, without using any chemicals such as dwarfing agents, a method of cultivating a flowering plant selected from the group consisting of the genus Petunia, the genus Pelargonium and the genus Euphorbia... > Method for producing Phalaenopsis clone plants through root tip culture (TS Zhou, JP)
Sapporo
Breweries
Ltd
N" 800762,EP z Process for the production of plants with enhanced growth characteristics (G Donn, P Eckes, DE)
Hoechst Schering GmbH
AgrEvo
N"801134,EP.
by targeted expression of a bacterial asparagines synthetase in the chloroplasts or plastides.
(P
ASB PCT.
. methods and compositions for obtaining transplastomic Arahidopsis and Bvassica plants. Specifically, the method provides culturing protocols and compositions that facilitate the regeneration of transformed plants following delivery of exogenous, beneficial DNA molecules.
> VMP-like sequences pathogenic Borrelia Norris et al, US)
of (SJ
Board of Regents, the University of Texas System and the inventors N"WOi9731123,
PCT
.. Also disclosed are the use of the nucleic acid sequences as probes or primers for the detection of organisms causing Lyme disease, relapsing fever, or related disorders, and kits designed to facilitate methods of using the described polypeptides, DNA segments and antibodies.
...
> Method for transfotming plant tissue (JJ Finer and HN Trick, US) 40 BIOFUTUR 173
l
Decembre1997
> Antibodies binding to monocyte chemoattractant protein 1 (MCP-1) receptor (CCRP) (P Lind et al, SE, ES)
Pharmacia & Upjohn AB, Consejo Superior de In-
: morceaux choisis avec I’lnpi
vestigaciones ventors NOW0197
and the in-
matitis, eg vaccines against allergy.
31949, PCT.
The claimed antibodies can be used for in vitro and/or in viuo diagnostic, for screening and detection of tissues and classes of cells expressing the MCP-1 receptor, for screening for new drugs and for therapeutic use... . ..
> Primers and probes for the amplification, detection and typing of Mycoplasma pneumoniae (CL Ovyn et al, BE, NL)
Akzo Nobel NV and the inventors N” WO 97/32036, PCT. > Determination gen genotype et al, RU)
l
of colla(S Ralston
Gemini International Holdings Ltd and the inventors N” WO 97132041, PCT. .. . A polymorphism in the collagen gene correlates with predisposition to osteoporosis, so diagnosis of a predisposition is achieved using the diagnostic means...
> Complexe immunomodulateur et son utilisation dans les affections par Helicobacter (FN TorosSian, FR)
FN Torossian N” WO 97/30716, PCT. Complexe vaccinal therapeutique specifique des bactCries Helicobacter et non sp&ifique agissant par immunomodulation permettant la regulation des d& fenses naturelles de l’organisme. Ce mCdicament permet Cgalement d’bviter les rPcidives, notamment dans le cas de r&istance aux traitements conventionnels. > Peptide immunogens for vaccination against and treatment of allergy (F Kricek and B Stadler, CH)
Novartis AG and the inventors N” WO 97131948. PCT. They are useful in, or for the preparation of, pharmaceutical compositions, particularly for the treatment of IgE-mediated diseases such as allergies and atopic der-
> Parapoxviruses containing foreign DNA, their production and their use in vaccines (N Schmeer et al, DE)
Bayer AG and the inventors N” WO 97132029. PCT. > Adeno-associated virus vector for boosting immunogenicity of cells (G Maass et a/, DE)
Medigene GmbH and the inventors N” WO 97/32988. PCT. > Recombinant AAV vector-based transduction systeme and use of same (G Maas et a/, DE)
Medigene GmbH and the inventors N” WO 97132989, PCT. > Vaccine compositions and methods useful in in‘ducing immune protection ,against atthritogenic pep.tides involved in the pa.thogenesis or rheumatoid #arthritis (DA Carson and S Albani, US)
‘The Regents of the Uni,versity of California N” WO 97134002, PCT.
> Combinaisons d’enzyrnes pour la destruction (de cellules proliferatives I[F Blanche et al, FR)
IRhBne-Poulenc Rorer N” 2746016, FR. . . Elle concerne Cgalement Ides vecteurs permettant le Irransfert et l’expression inlrracellulaire de ces combilnaisons d’enzymes, ainsi que ‘leur utilisation thkrapeutique, Ien particulier en thirapie g& Inique anticancCreuse. :> MBthode de traitement lpar th&apie genique des tumeurs humaines et virus lrecombin& correspondants (T Boon Falleur et ial, FR)
(CNRS, lnstitut GustaveIRoussy et Ludwig Institute for Cancer Research N” 2746110, FR. ,.. Elle concerne en particulier des virus recombin& defectifs portant une sCquence (codant pour un antigcne
les derniers brevets dkposes realisee en collaboration
Pro vti > Cultivation of petunia Ohtani et a/, JP)
(T
National Research Institute of Agricultural Engineering, Ministry of Agriculture, Forestry and Fisheries N"799564,
EP
To make it possible to control the external view of flowers of petunias not by breeding but by only controlling cultivation environment... Especially, to broaden the outer margin in the corolla of the petunia, it is preferable to use yellow light as the cultivation light, and to narrow it, blue light as the light quality.
The Ohio State Research Foundation NOW0 97/32016, PCT . . . comprises combining the plant and a vector which contains the foreign nucleic acid to be introduced into the plant sample. Preferably the plant sample is sonicated in the presence of the vector. The vector is preferably non-tumor inducing bacteria more preferably Agrobacteviurn... After sonicating the plant sample is cultured under conditions that induce morphogenesis to produce plant tissue that will mature into a transformed plant. > Plastid transformation in Arabidopsis thaliana Maliga et al, IN)
Rutgers University, and the inventors NOW0 97132977,
> Cultivation of flowering plants (T Ohtani et al, JP)
National Research Institute of Agricultural Engineering, Ministry of Agriculture, Forestry and Fisheries N” 799565, EP. To make it possible to control the forms of flowering plants by controlling light quality of cultivation light, without using any chemicals such as dwarfing agents, a method of cultivating a flowering plant selected from the group consisting of the genus Petunia, the genus Pelargonium and the genus Euphorbia... > Method for producing Phalaenopsis clone plants through root tip culture (TS Zhou, JP)
Sapporo
Breweries
Ltd
N" 800762,EP z Process for the production of plants with enhanced growth characteristics (G Donn, P Eckes, DE)
Hoechst Schering GmbH
AgrEvo
N"801134,EP.
by targeted expression of a bacterial asparagines synthetase in the chloroplasts or plastides.
(P
ASB PCT.
. methods and compositions for obtaining transplastomic Arahidopsis and Bvassica plants. Specifically, the method provides culturing protocols and compositions that facilitate the regeneration of transformed plants following delivery of exogenous, beneficial DNA molecules.
> VMP-like sequences pathogenic Borrelia Norris et al, US)
of (SJ
Board of Regents, the University of Texas System and the inventors N"WOi9731123,
PCT
.. Also disclosed are the use of the nucleic acid sequences as probes or primers for the detection of organisms causing Lyme disease, relapsing fever, or related disorders, and kits designed to facilitate methods of using the described polypeptides, DNA segments and antibodies.
...
> Method for transfotming plant tissue (JJ Finer and HN Trick, US) 40 BIOFUTUR 173
l
Decembre1997
> Antibodies binding to monocyte chemoattractant protein 1 (MCP-1) receptor (CCRP) (P Lind et al, SE, ES)
Pharmacia & Upjohn AB, Consejo Superior de In-
: morceaux choisis avec I’lnpi
vestigaciones ventors NOW0197
and the in-
matitis, eg vaccines against allergy.
31949, PCT.
The claimed antibodies can be used for in vitro and/or in viuo diagnostic, for screening and detection of tissues and classes of cells expressing the MCP-1 receptor, for screening for new drugs and for therapeutic use... . ..
> Primers and probes for the amplification, detection and typing of Mycoplasma pneumoniae (CL Ovyn et al, BE, NL)
Akzo Nobel NV and the inventors N” WO 97/32036, PCT. > Determination gen genotype et al, RU)
l
of colla(S Ralston
Gemini International Holdings Ltd and the inventors N” WO 97132041, PCT. .. . A polymorphism in the collagen gene correlates with predisposition to osteoporosis, so diagnosis of a predisposition is achieved using the diagnostic means...
> Complexe immunomodulateur et son utilisation dans les affections par Helicobacter (FN TorosSian, FR)
FN Torossian N” WO 97/30716, PCT. Complexe vaccinal therapeutique specifique des bactCries Helicobacter et non sp&ifique agissant par immunomodulation permettant la regulation des d& fenses naturelles de l’organisme. Ce mCdicament permet Cgalement d’bviter les rPcidives, notamment dans le cas de r&istance aux traitements conventionnels. > Peptide immunogens for vaccination against and treatment of allergy (F Kricek and B Stadler, CH)
Novartis AG and the inventors N” WO 97131948. PCT. They are useful in, or for the preparation of, pharmaceutical compositions, particularly for the treatment of IgE-mediated diseases such as allergies and atopic der-
> Parapoxviruses containing foreign DNA, their production and their use in vaccines (N Schmeer et al, DE)
Bayer AG and the inventors N” WO 97132029. PCT. > Adeno-associated virus vector for boosting immunogenicity of cells (G Maass et a/, DE)
Medigene GmbH and the inventors N” WO 97/32988. PCT. > Recombinant AAV vector-based transduction systeme and use of same (G Maas et a/, DE)
Medigene GmbH and the inventors N” WO 97132989, PCT. > Vaccine compositions and methods useful in in‘ducing immune protection ,against atthritogenic pep.tides involved in the pa.thogenesis or rheumatoid #arthritis (DA Carson and S Albani, US)
‘The Regents of the Uni,versity of California N” WO 97134002, PCT.
> Combinaisons d’enzyrnes pour la destruction (de cellules proliferatives I[F Blanche et al, FR)
IRhBne-Poulenc Rorer N” 2746016, FR. . . Elle concerne Cgalement Ides vecteurs permettant le Irransfert et l’expression inlrracellulaire de ces combilnaisons d’enzymes, ainsi que ‘leur utilisation thkrapeutique, Ien particulier en thirapie g& Inique anticancCreuse. :> MBthode de traitement lpar th&apie genique des tumeurs humaines et virus lrecombin& correspondants (T Boon Falleur et ial, FR)
(CNRS, lnstitut GustaveIRoussy et Ludwig Institute for Cancer Research N” 2746110, FR. ,.. Elle concerne en particulier des virus recombin& defectifs portant une sCquence (codant pour un antigcne